1-11 of 11
Gian Paolo Tonini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Somatic Mutations Enriched in Cis-Regulatory Elements Affect Genes Involved in Embryonic Development and Immune System Response in Neuroblastoma

Vito Alessandro Lasorsa, Annalaura Montella, Sueva Cantalupo, Matilde Tirelli, Carmen de Torres, Sanja Aveic, Gian Paolo Tonini, Achille Iolascon, Mario Capasso
Journal: Cancer Research
Cancer Res (2022) 82 (7): 1193–1207.
https://doi.org/10.1158/0008-5472.CAN-20-3788
Published: 01 April 2022
View articletitled, Somatic Mutations Enriched in Cis-Regulatory Elements Affect Genes Involved in Embryonic Development and Immune System Response in Neuroblastoma
Open the PDF for Somatic Mutations Enriched in Cis-Regulatory Elements Affect Genes Involved in Embryonic Development and Immune System Response in Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma

Eveline Barbieri, Katleen De Preter, Mario Capasso, Zaowen Chen, Danielle M. Hsu, Gian Paolo Tonini, Steve Lefever, John Hicks, Rogier Versteeg, Andrea Pession, Frank Speleman, Eugene S. Kim, Jason M. Shohet
Journal: Cancer Research
Cancer Res (2014) 74 (3): 765–774.
https://doi.org/10.1158/0008-5472.CAN-13-1315
Published: 02 February 2014
View articletitled, Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma
Open the PDF for Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Abstract 5050: KCNJ2 constitutes a marker and therapeutic target of high-risk medulloblastomas.

Francesca Valdora, Florian Freier, Livia Garzia, Vijay Ramaswamy, Claudia Seyler, Thomas Hielscher, Nathan Brady, Paul A. Northcott, Marcel Kool, David TW Jones, Hendrik Witt, Gian Paolo Tonini, Wolfram Scheurlen, Hugo A. Katus, Andreas E. Kulozik, Edgar Zitron, Andrey Korshunov, Peter Lichter, Michael D. Taylor, Stefan M. Pfister, Marc Remke
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5050.
https://doi.org/10.1158/1538-7445.AM2013-5050
Published: 15 April 2013
View articletitled, Abstract 5050: KCNJ2 constitutes a marker and therapeutic target of high-risk medulloblastomas.
Journal Articles

Abstract 1424: KCNJ2 comprises a marker of poor prognosis and a therapeutic target in non-WNT/non-SHH medulloblastoma

Francesca Valdora, Florian Freier, Claudia Seyler, Nathan Brady, Dominique Kranz, Thomas Hielscher, Sebastian Bender, Paul Northcott, Marcel Kool, David Jones, Hendrik Witt, Marina Ryzhova, Sabrina Pleier, Simona Coco, Gian Paolo Tonini, Axel Benner, Andreas von Deimling, Wolfram Scheurlen, Michael Boutros, Michael Taylor, Hugo Katus, Andreas Kulozik, Peter Lichter, Andrey Korshunov, Edgar Zitron, Stefan Pfister, Marc Remke
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1424.
https://doi.org/10.1158/1538-7445.AM2012-1424
Published: 15 April 2012
View articletitled, Abstract 1424: KCNJ2 comprises a marker of poor prognosis and a therapeutic target in non-WNT/non-SHH medulloblastoma
Journal Articles

Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients

Lorena Passoni, Luca Longo, Paola Collini, Addolorata Maria Luce Coluccia, Fabio Bozzi, Marta Podda, Andrea Gregorio, Claudio Gambini, Alberto Garaventa, Vito Pistoia, Federica Del Grosso, Gian Paolo Tonini, Mangeng Cheng, Carlo Gambacorti-Passerini, Andrea Anichini, Franca Fossati-Bellani, Massimo Di Nicola, Roberto Luksch
Journal: Cancer Research
Cancer Res (2009) 69 (18): 7338–7346.
https://doi.org/10.1158/0008-5472.CAN-08-4419
Published: 14 September 2009
View articletitled, Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients
Open the PDF for Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients in another window
Includes: Supplementary data
Journal Articles

Abstract #5678: Overexpression of ALK correlates with poor prognosis neuroblastoma patients regardless of activating mutations

Luca Longo, Paola Collini, Andrea Gregorio, Claudio Gambini, Alberto Garaventa, Vito Pistoia, Federica Del Grosso, Raffaella Defferrari, Marilena De Mariano, Gian Paolo Tonini, Mangeng Cheng, Andrea Anichini, Franca Fossati-Bellani, Roberto Luksch, Lorena Passoni
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5678.
Published: 01 May 2009
View articletitled, Abstract #5678: Overexpression of ALK correlates with poor prognosis neuroblastoma patients regardless of activating mutations
Journal Articles

Identification of ALK as the major familial neuroblastoma predisposition gene

Yael Mosse, Marci Laudenslager, Luca Longo, Patrizia Perri, Gian Paolo Tonini, Rani George, Megan Hanna, Heidi Greulich, Matthew Meyerson, A. Look, Carmel McConville, Genevieve Laureys, Frank Speleman, Cuiping Hou, Cecilia Kim, Hakon Hakonarson, Garrett Brodeur, Eric Rappaport, Marcella Devoto, John Maris
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): LB-237.
Published: 01 May 2008
View articletitled, Identification of ALK as the major familial neuroblastoma predisposition gene
Journal Articles

PHOX2B mutations and familial neuroblastoma

Patrizia Perri, Tiziana Bachetti, Luca Longo, Ivana Matera, Marco Seri, Gian Paolo Tonini, Isabella Ceccherini
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 303.
Published: 01 May 2005
View articletitled, PHOX2B mutations and familial neuroblastoma
Journal Articles

A genome-wide screening for neuroblastoma susceptibility loci

Luca Longo, Marco Seri, Marcella Devoto, Francesca Schena, Giovanni Romeo, Gian Paolo Tonini, Patrizia Perri
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 303–304.
Published: 01 May 2005
View articletitled, A genome-wide screening for neuroblastoma susceptibility loci
Journal Articles

Expression of B-myb in Neuroblastoma Tumors Is a Poor Prognostic Factor Independent from MYCN Amplification

Giuseppe Raschellà, Vincenzo Cesi, Roberto Amendola, Anna Negroni, Barbara Tanno, Pierluigi Altavista, Gian Paolo Tonini, Bruno De Bernardi, Bruno Calabretta
Journal: Cancer Research
Cancer Res (1999) 59 (14): 3365–3368.
Published: 15 July 1999
View articletitled, Expression of B-myb in Neuroblastoma Tumors Is a Poor Prognostic Factor Independent from MYCN Amplification
Open the PDF for Expression of B-myb in Neuroblastoma Tumors Is a Poor Prognostic Factor Independent from MYCN Amplification in another window
Journal Articles

Inducible Expression of Calcyclin, a Gene with Strong Homology to S-100 Protein, during Neuroblastoma Cell Differentiation and Its Prevalent Expression in Schwann-like Cell Lines

Gian Paolo Tonini, Antonella Casalaro, Andrea Cara, Daniela Di Martino
Journal: Cancer Research
Cancer Res (1991) 51 (6): 1733–1737.
Published: 01 March 1991
View articletitled, Inducible Expression of Calcyclin, a Gene with Strong Homology to S-100 Protein, during Neuroblastoma Cell Differentiation and Its Prevalent Expression in Schwann-like Cell Lines
Open the PDF for Inducible Expression of Calcyclin, a Gene with Strong Homology to S-100 Protein, during Neuroblastoma Cell Differentiation and Its Prevalent Expression in Schwann-like Cell Lines in another window